Systemic treatment with corticosteroids in psoriasis-health care provision far beyond the S3-guidelines;Systemische Glukokortikosteroide bei Psoriasis - Versorgung jenseits der S3-Leitlinie

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue 10, 2011, Pages 833-838

  Augustin, Matthias ^a   Schäfer, Ines ^a   Reich, Kristian ^b   Glaeske, Gerd ^c   Radtke, Marc ^a  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b Dermatologikum Hamburg ^*  (Germany)

^c UNIVERSITY OF BREMEN   (Germany)

Author keywords

biologicals; corticosteroids; health care; psoriasis; S3 guideline; systemic drugs

Indexed keywords

BETAMETHASONE; CLOPREDNOL; CORTISONE; CYCLOSPORIN A; DEFLAZACORT; DEXAMETHASONE; FLUOCORTOLONE; FUMARIC ACID DERIVATIVE; GLUCOCORTICOID; HYDROCORTISONE; MEPREDNISONE; METHOTREXATE; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; RETINOID DERIVATIVE; RIMEXOLONE; TRIAMCINOLONE;

ARTICLE; COMORBIDITY; FEMALE; GERMANY; HEALTH CARE COST; HEALTH INSURANCE; HEALTH PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; PRACTICE GUIDELINE; PRESCRIPTION; PSORIASIS; PSORIATIC ARTHRITIS;

ADMINISTRATION, ORAL; ADRENAL CORTEX HORMONES; ANTI-INFLAMMATORY AGENTS; CYCLOSPORINE; DRUG UTILIZATION; FEMALE; FUMARATES; GENERAL PRACTICE; GERMANY; GUIDELINE ADHERENCE; HUMANS; INTERNAL MEDICINE; MALE; METHOTREXATE; OFF-LABEL USE; PSORIASIS; RETINOIDS;

EID: 80053627034     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07713.x     Document Type: Article

References (12)

1. Nast A, Kopp IB, Augustin M, Banditt KB, Boehncke WH, Follmann M, Friedrich M, Huber M, Kahl C, Klaus J, Koza J, Kreiselmaier I, Mohr J, Mrowietz U, Ockenfels HM, Orzechowski H-D, Prinz J, Reich K, Rosenbach T, Rosumeck S, Schlaeger M, Schmid-Ott G, Sebastian M, Streit V, Weberschock T, Rzany B,. S3-Leitli-nie zur Therapie der Psoriasis vulgaris. J Dtsch Dermatol Ges 2006; 4: S1- S126.
2. Nast A, Boehncke WH, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Sammain A, Schlaeger M, Sebastian M, Sterry W, Streit V, Augustin M, Erdmann R, Klaus J, Kozal J, Muller S, Orzechowski HJ, Rosumeck S, Schmid-Ott G, Weber-schock T, Rzany B,. S3-Leitlinie zur Therapie der Psoriasis vulgaris.
3. Menter A, Korman NJ, Elmets CA, Feldman SR, Gelfand JM, Gordon KB, Gottlieb AB, Koo JY, Lebwohl M, Lim HW, Van Voorhees AS, Beutner KR, Bhushan R,. Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009; 61: 451-485.
4. Spuls PI, Tuut MK, van Everdingen JJ, de Rie MA,. Werkgroep Psoriasis van de Nederlandse Vereniging voor Dermato-logie en Venereologie. [The practice guideline 'Photo(chemo)therapy and systemic therapy in severe chronic plaque-psoriasis']. Ned Tijdschr Geneeskd 2004; 148: 2121-2125. Review. Dutch.
5. Pathirana D, Ormerod AD, Saiag P, Smith C, Spuls PI, Nast A, Barker J, Bos JD, Burmester GR, Chimenti S, Dubertret L, Eberlein B, Erdmann R, Ferguson J, Girolomoni G, Gisondi P, Giunta A, Griffiths C, Hönigsmann H, Hussain M, Jobling R, Karvonen SL, Kemeny L, Kopp I, Leonardi C, Maccarone M, Menter A, Mrowietz U, Naldi L, Nijsten T, Ortonne J P, Orzechowski HD, Rantanen T, Reich K, Reytan N, Richards H, Thio HB, van de Kerkhof P, Rzany B,. European S3-guidelines on the systemic treatment of psoriasis vulgaris. J Eur Acad Dermatol Venereol 2009; 23: Suppl 2: 1-70.
6. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K,. Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter prospective cross-sectional study in Germany. Dermatology 2008; 216: 366-372. (Pubitemid 351630108)
7. Radtke MA, Augustin J, Blome C, Reich K, Rustenbach SJ, Schäfer I, Laass A, Augustin M,. Welchen Einfluss haben re-gionale Faktoren auf die Versorgung der Psoriasis in Deutschland? J Dtsch Der-matol Ges 2010; 8: 516-524.
8. Fricke U, Günther J, Anette Zawinell,. Methodik der ATC-Klassifikation und DDD-Festlegung für den deutschen Arzneimittelmarkt, Herausgegeben vom WIdO, Bonn, 2007.
9. Augustin M, Reich K, Glaeske G, Scha-efer I, Radtke MA,. Comorbidity and age-related prevalence of psoriasis-analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-151.
10. Schäfer I, Rustenbach SJ, Zimmer L, Augustin M,. Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008; 217: 169-172.
11. Schmitt J, Schmitt NM, Kirch W, Meurer M,. Outpatient care and medical treatment of children and adults with atopic eczema. J Dtsch Dermatol Ges 2009; 7: 345-351. English, German.
12. Augustin M, Reich K, Reich C, Purwins S, Rustenbach SJ, Schäfer I, Radtke M,. Versorgungsqualität der Psoriasis vulgaris in Deutschland-Ergebnisse der Nationalen Versorgungs-studie PsoHealth 2007 [Quality of psoriasis care in Germany-results of the national study PsoHealth 2007]. J Dtsch Dermatol Ges 2008; 6: 640- 646.